Features Read the April 2018 Digital Edition

Read the April 2018 Digital Edition

Read the April 2018 issue in its entirety.

Pipeline High-profile candidates challenge marketers well in advance of launch

High-profile candidates challenge marketers well in advance of launch

With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in immunology, pain management, and melanoma challenge marketers well in advance of launch.

Commercial Pro ad report 2017: Ad revenue plunged for print-first publishers

Pro ad report 2017: Ad revenue plunged for print-first publishers

The 2017 numbers aren't kind to print-first publishers. Is this a blip in print's fortunes or the start of a long-predicted decline?

Commercial Dr. Reddy's Laboratories CEO of developed markets Alok Sonig makes Wall Street listen

Dr. Reddy's Laboratories CEO of developed markets Alok Sonig makes Wall Street listen

Alok Sonig, chief executive officer of developed markets at Dr. Reddy's Laboratories, articulates the benefits of generics.

Features Read the March 2018 Digital Edition

Read the March 2018 Digital Edition

Read the March 2018 issue in its entirety.

Campaigns DTC ads 2017: The good, the bad, and the ugly

DTC ads 2017: The good, the bad, and the ugly

We considered pharma and healthcare ads that, per iSpotTV, started airing no earlier than January 2017.

Campaigns DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

DTC Report 2018: Will more supersized campaigns follow Opdivo's and Keytruda's massive strikes?

Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?

Technology Infographic | AI's impact on patients and caregivers

Infographic | AI's impact on patients and caregivers

Caregivers and patients predict how the use of AI will affect them.

Commercial ICER said a $14,000 drug should be a fraction of the cost. Why its makers listened.

ICER said a $14,000 drug should be a fraction of the cost. Why its makers listened.

In an unusual twist, the makers of cholesterol drug Praluent are re-pricing the treatment to align with the nonprofit's recommendation. Is industry warming to ICER?

Legal/Regulatory McCaskill takes aim at DTC ad tax deduction; measure expected to face stiff resistance

McCaskill takes aim at DTC ad tax deduction; measure expected to face stiff resistance

Pharma companies are likely to put up aggressive resistance to the measure, introduced earlier this month.

Technology AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practice

The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.

Top 40 Transformers MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M announces its 2018 Healthcare Transformer and Innovation Catalyst honorees

MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.

Features Rise of the health-tech ethicist

Rise of the health-tech ethicist

Want to get an ethicist agitated? Mention the integration of voice-activation and other tech into healthcare. Experts say navigating this area is a work in progress.

Commercial Infographic | What Makes Patients Tick?

Infographic | What Makes Patients Tick?

Now more than ever, patients aren't shy about sharing their wants and needs. Here, 8,000 patients from three generations in the U.S., U.K., Germany, and France weigh in on everything from brand loyalty to the factors that drive their decision-making-processes to the reasons they switch treatments.

Features Has DTC in the oncology space kept up with science?

Has DTC in the oncology space kept up with science?

As oncology drugs save or extend the lives of many more patients than anyone could have imagined a few years ago, a new challenge has emerged in the wake of their approval: Selling them to patients scared about their prognosis and alternately ignorant of and skeptical about recent breakthroughs in treatment.

Agencies Ortho CEO leads massive turnaround

Ortho CEO leads massive turnaround

When Ortho Clinical Diagnostics lived under the roof of Johnson & Johnson, it had the luxury of focusing on its product and service mix — and not a whole lot else.

Features Xbox for Docs: Pharma backs AR games for use in physician learning

Xbox for Docs: Pharma backs AR games for use in physician learning

Pharma has backed a number of AR-based games for physician learning and marketing. They're meant to complement live learning, but mobile games may do a better job teaching certain skills.

Features Marketers Trend Report 2018: Relief after one year of Trump doesn't mitigate all concerns

Marketers Trend Report 2018: Relief after one year of Trump doesn't mitigate all concerns

The general sense: Nobody should get comfortable with the status quo

Features Read the February 2018 Digital Edition

Read the February 2018 Digital Edition

Read the February 2018 issue in its entirety.

Legal/Regulatory Azar's tough assignment: 'Rocketing down' drug prices

Azar's tough assignment: 'Rocketing down' drug prices

The new HHS secretary has been given a difficult task by President Trump: bring drug prices down.

Commercial Infographic | Highlighting top healthcare trends

Infographic | Highlighting top healthcare trends

There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy to lose sight of everything else. PwC's Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.

Agencies 10 myths about millennials and their healthcare habits

10 myths about millennials and their healthcare habits

More has been written about millennials — and their healthcare habits — than about any other generation. Here, Gen Y marketers explain why most of what you've read is wrong.

Corporate 2018 MAHF: Leverte 'was as good with clients as anyone you've ever seen'

2018 MAHF: Leverte 'was as good with clients as anyone you've ever seen'

Zero people have such tales about Robert Leverte, which is why news of his pending induction into the Medical Advertising Hall of Fame was received warmly when it was made public last October.

Features Big Predictions: Agency gurus on the future of data in the industry

Big Predictions: Agency gurus on the future of data in the industry

We asked some of the agency world's sharpest data people to answer a pair of questions about the future of data in and around pharma marketing. Here's what they had to say.

Features High five: How these companies are leveraging data to engage A-list HCPs

High five: How these companies are leveraging data to engage A-list HCPs

In the past, pharma hasn't used data effectively to engage its A-list HCPs. Five companies hope to change that.

Features Real-world evidence: It's finally having its moment

Real-world evidence: It's finally having its moment

Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled

Features Cost over sight? Spark's blindness cure has the industry talking

Cost over sight? Spark's blindness cure has the industry talking

Spark has priced its cure for a rare form of blindness at $425,000 per eye. But rather than the science or the cost, pharma is buzzing over the company's outcomes-based pricing model

Features As CAR-Ts go from candidates to brands, what's the marketing strategy?

As CAR-Ts go from candidates to brands, what's the marketing strategy?

Strategies for differentiating CAR-T therapies emerge in the early days of 2018, while competitors race to catch up with Novartis and Gilead.

Features Get to know your data scientist: Four data aces share their knowledge

Get to know your data scientist: Four data aces share their knowledge

Four data aces share their backgrounds, inspirations, and guiding philosophies

Features Read the January 2018 Digital Edition

Read the January 2018 Digital Edition

Read the January 2018 issue in its entirety.

Corporate Flexion's pivot proves pain-free

Flexion's pivot proves pain-free

Clayman says the company's next 18 months are all about Zilretta, with further pipeline construction next up.

Features Back to the Future: Print media thrives in point of care

Back to the Future: Print media thrives in point of care

Not only isn't print dead, as ahead-of-themselves media wonks have claimed for the past decade, but it's thriving in a most unlikely environment: the point of care

Commercial Infographic | Docs, payers need pharma to step up

Infographic | Docs, payers need pharma to step up

For all the talk about new and better ways to engage, pharma still hasn't created an appreciably higher volume of satisfied — or informed — customers.

Features No Google, no problem: Pharma partners with China's tech giants

No Google, no problem: Pharma partners with China's tech giants

In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market

Features The buyer's guide to pharma, healthcare, and life sciences consultancies

The buyer's guide to pharma, healthcare, and life sciences consultancies

Do the healthcare and pharma arms of Accenture, Deloitte, PwC, and other consultancies pose an existential threat to traditional healthcare agencies?

Features Should pharma fear ICER?

Should pharma fear ICER?

The group's reports, received with great interest by insurers and the Department of Veteran Affairs, have concluded certain high-profile drugs aren't worth the cost. Pharma still hasn't decided whether ICER is friend or foe.

Corporate Amarin's Salyer preps for Vascepa push

Amarin's Salyer preps for Vascepa push

Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has "a great story to tell, with or without the data."

Commercial Infographic | HCPs must deal with communication breakdown

Infographic | HCPs must deal with communication breakdown

Drugmakers are proud of the patient service programs they've developed. Yet there remains a disconnect in the way information is communicated to HCPs.

Features Experts weigh in: How will health technology advance in 2018?

Experts weigh in: How will health technology advance in 2018?

Innovation-minded executives share their thoughts and predictions for the year ahead.

Pipeline The 2018 pipeline report: Aspiring assets to keep an eye on

The 2018 pipeline report: Aspiring assets to keep an eye on

The most promising products in pharma's pipeline will compete in a landscape that increasingly rewards big risks and places an emphasis on novel mechanisms. That comes with a catch.

Features

Read the December 2017 Digital Edition

Read the December 2017 issue in its entirety.

Features Read the November 2017 Digital Edition

Read the November 2017 Digital Edition

Read the November 2017 issue in its entirety.

Sponsored Speaker bureaus must change to stay relevant, experts say

Speaker bureaus must change to stay relevant, experts say

To remain relevant, speakers bureaus must evolve to a strategic marketing tactic with personalized messaging to the customer.

Commercial How Aubagio became the most switched-to oral MS drug

How Aubagio became the most switched-to oral MS drug

Second to market and dismissed as inferior to the competition, Sanofi's Aubagio seemed destined for lower-tier status. Here's how it overcame the initial obstacles and, five years later, become a potent market force

Careers

The MM&M 2017 Career and Salary Survey Premium Edition

This year's offering includes access to the most current and in-depth data on salary and compensation trends, job satisfaction, recruitment and retention tactics, and more.

Features Read the October 2017 digital edition

Read the October 2017 digital edition

Read the October 2017 issue in its entirety, including our Career and Salary Survey.

Campaigns Medical journal ad spend in H1 2017: All the data in one place

Medical journal ad spend in H1 2017: All the data in one place

The top three most advertised brands were GlaxoSmithKline's Breo Ellipta, Eli Lilly's Trulicity, and Boehringer Ingelheim's Jardiance.

Careers The professional paths of 8 pharma execs

The professional paths of 8 pharma execs

The successes of these pharma execs show that there's no one path to professional bliss.

Sponsored AbelsonTaylor's Jay Carter on the key to retaining top talent

AbelsonTaylor's Jay Carter on the key to retaining top talent

Now that Facebook, Apple, and Google have set their sights on healthcare, agencies find themselves under pressure from yet another flank.

Careers Pharma marketing salaries reach new heights, up 12.7% in 2017

Pharma marketing salaries reach new heights, up 12.7% in 2017

Salaries are up — by a lot — and marketers are enthusiastic about their career prospects.

Features Read the September 2017 digital edition

Read the September 2017 digital edition

Read the September 2017 issue in its entirety, including how marketing can save clinical trials.

Pipeline Infographic | How often are drugmakers sharing clinical-trial data?

Infographic | How often are drugmakers sharing clinical-trial data?

The answer: it depends on what phase the trial is in.

Commercial Drugmakers turn to social — not TV — to market drugs to women

Drugmakers turn to social — not TV — to market drugs to women

Still, most experts characterize this year's newly approved women's health drugs as modest improvements rather than groundbreaking advances in medicine.

Commercial Top 25 women's health brands, based on U.S. sales in 2016

Top 25 women's health brands, based on U.S. sales in 2016

Amgen's Prolia tops the list, according to data compiled by EvaluatePharma.

Agencies Healthcare agencies re-evaluate tactics to retain talent

Healthcare agencies re-evaluate tactics to retain talent

The best marketers possess a mix of scientific know-how, digital dexterity, and unflappability. To keep them, agencies need to revise their thinking and tactics.

Pipeline Can marketing techniques save clinical trials?

Can marketing techniques save clinical trials?

No crucial area in pharma is more desperately in need of a fix — or more stubbornly resistant to change.

Commercial Infographic | The leaders of the global hepatitis-C market

Infographic | The leaders of the global hepatitis-C market

Despite approvals of competing products from AbbVie, Merck, and Bristol-Myers Squibb, Gilead remains the market leader.

Technology Experts say pharma's move to Snapchat is in the making

Experts say pharma's move to Snapchat is in the making

Alone among the best-known social platforms, Snapchat has failed to generate much enthusiasm from pharma. Here's why — and here's why that may change.

Features Read the complete August 2017 digital edition

Read the complete August 2017 digital edition

Read the August 2017 issue in its entirety, including our recap of the MM&M Hall of Femme event.

Commercial Why Sanofi's dengue fever vaccine fell short of expectations

Why Sanofi's dengue fever vaccine fell short of expectations

Dengvaxia's post-launch plight reflects the difficulties of launching a vaccine. Is this a harbinger for future vaccine-marketing efforts?

Commercial Top 25 vaccine products in 2016, based on U.S. sales

Top 25 vaccine products in 2016, based on U.S. sales

Pfizer's Prevnar tops the list, according to data compiled by EvaluatePharma.

Corporate Horizon CEO Tim Walbert knows patients because he is one

Horizon CEO Tim Walbert knows patients because he is one

He was diagnosed years ago with a handful of autoimmune conditions, treating them with drugs like Abbvie's Humira, which he helped commercialize.

Commercial Investors put their money on point of care

Investors put their money on point of care

Two recent cash infusions suggest investors are bullish on point-of-care advertising. Is the channel ready for its moment in the spotlight?

Commercial Top 25 oncology brands in 2016, based on U.S. sales

Top 25 oncology brands in 2016, based on U.S. sales

Celgene's Revlimid tops the list, according to data compiled by EvaluatePharma.

Technology Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

Technology Drugmakers test out Tumblr, to tap specific audiences

Drugmakers test out Tumblr, to tap specific audiences

Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.

Commercial Pharma companies, now marketing high-science drugs, rely more on medical affairs

Pharma companies, now marketing high-science drugs, rely more on medical affairs

Five years ago, the notion of medical science liaisons as a guiding voice in the marketing mix was borderline preposterous. Now they're called upon early and often.

Sponsored Roundtable: Market access takes center stage

Roundtable: Market access takes center stage

Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.

Careers From diversity to pricing issues, BMS marketing chief strikes a balance

From diversity to pricing issues, BMS marketing chief strikes a balance

Susan Sweeney has earned a reputation for such pragmatism and attentiveness to the things that really matter.

Features Read the complete July 2017 digital edition

Read the complete July 2017 digital edition

Read the 2017 Agency Issue in its entirety.

MMM Hall of Femme Photo | The 2017 Hall of Femme

Photo | The 2017 Hall of Femme

Meet 13 of our 16 Hall of Femme honorees.

Technology Drugmakers turn to tech to better demonstrate empathy

Drugmakers turn to tech to better demonstrate empathy

Frustrated by its inability to empathize with patients, pharma has turned to tech to teach providers and caregivers what illness really feels like.

Sponsored Populism and Creativity, Live from Cannes, Presented by McCann Health

Populism and Creativity, Live from Cannes, Presented by McCann Health

McCann Health, Cannes Lions Healthcare Network of the Year, hosted a roundtable to discuss the role of creativity in a new world order where populism is undermining trust.

Agencies 9 under the radar healthcare agencies to watch in 2017

9 under the radar healthcare agencies to watch in 2017

Here are nine agencies that are gaining traction in healthcare marketing.

Agencies MM&M's 2017 healthcare agency solar system

MM&M's 2017 healthcare agency solar system

Discover how M&A activity in 2016 and 2017 has reshaped North American healthcare agencies and the holding companies that own them.

Agencies The MM&M Agency Issue | The archives

The MM&M Agency Issue | The archives

Here you'll find the last four years of the MM&M Agency Issue.

Agencies Agencies embrace health, in bid to diversify beyond pharma

Agencies embrace health, in bid to diversify beyond pharma

Healthcare networks instigated a broad set of changes in a grand embrace of non-pharma business that diversified revenue streams and took specialist agencies out of their comfort zones.

Agencies The top 100 healthcare agencies, ranked by 2016 revenue

The top 100 healthcare agencies, ranked by 2016 revenue

Havas Health & You, WPP Health & Wellness, and Klick Health reported the highest revenue last year.

Agencies Questions for 5 of the healthcare agency world's top execs

Questions for 5 of the healthcare agency world's top execs

The CEOs of the industry's largest holding companies discuss how they're reasserting their businesses.

Agencies MM&M's 2017 Agency Issue

MM&M's 2017 Agency Issue

Read on for more about the top performing firms, the trends shaping the business, and the story behind each of the top 100 agencies.

Features Read the complete Patient Journey 2017 digital edition

Read the complete Patient Journey 2017 digital edition

Here you'll find everything from the Patient Journey 2017 supplement to our June issue.

Features Read the complete June 2017 digital edition

Read the complete June 2017 digital edition

Here you'll find everything from our June 2017 issue, including our Pharma Report, our Hall of Femme, and two roundtable discussions on media and oncology.

Sponsored Roundtable: When it comes to media, pharma compares the new with the old

Roundtable: When it comes to media, pharma compares the new with the old

In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.

Sponsored Roundtable: Social centricity in oncology

Roundtable: Social centricity in oncology

Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family support.

Commercial 2017 Pharma Report: All the data in one place

2017 Pharma Report: All the data in one place

Find data on patent expirations, new drug approvals, top therapeutic classes, and top-selling drugs.

Commercial Pricing pressure is the new new normal for drugmakers

Pricing pressure is the new new normal for drugmakers

Drug prices, as you may have heard, are kind of high. But price growth has slowed after sharp spikes in 2014 and 2015.

Sponsored Expert Q&A: Getting patient centricity right

Expert Q&A: Getting patient centricity right

Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.

Features Read the complete May 2017 digital edition

Read the complete May 2017 digital edition

Here you'll find everything from our May 2017 issue, including our Top 40 Transformers, deep dive into autoimmune drugs, and more.

Commercial Back at Dendreon, Caggiano takes on Provenge's comeback

Back at Dendreon, Caggiano takes on Provenge's comeback

Jim Caggiano had witnessed Provenge's birth during an earlier turn at Dendreon and couldn't understand what went wrong.

Features Read the complete 2017 Game Changers digital edition

Read the complete 2017 Game Changers digital edition

Here you'll find Sara Holoubek's deep dive into how pharma is tackling some of its biggest challenges.

Careers J&J's Joaquin Duato: Diversity is 'essential'

J&J's Joaquin Duato: Diversity is 'essential'

Under Duato, the leadership team for Johnson & Johnson's pharma group includes six women. "We don't just talk about it," he says.

Commercial 4 reasons why patients don't fill their prescriptions

4 reasons why patients don't fill their prescriptions

Researchers still don't know why Americans who are prescribed a prescription drug to treat a chronic condition or disease so often fail to fill those prescriptions.

Commercial Drugmakers battle for slice of Humira's billions

Drugmakers battle for slice of Humira's billions

Makers of biosimilars have targeted a few of the top-selling autoimmune drugs. Get ready for some of the highest-stakes pricing and access skirmishes in recent pharma history.

Pipeline MedImmune goes after challenging lupus market

MedImmune goes after challenging lupus market

While investments in investigational lupus agents appear to be heating up, late-stage clinical failure continues to be a major hurdle to market entry.

Commercial Top 25 autoimmune brands in 2016, based on U.S. sales

Top 25 autoimmune brands in 2016, based on U.S. sales

AbbVie's Humira tops the list, according to data compiled by EvaluatePharma.

Features Read the complete April 2017 digital edition

Read the complete April 2017 digital edition

Here you'll find everything you need to know from MM&M's April 2017 issue, including our DTC report, our deep dive into respiratory drugs, and more.

Commercial 5 of healthcare's hardest nuts to crack

5 of healthcare's hardest nuts to crack

How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?

MMM Hall of Femme Hall of Femme of 2017

Hall of Femme of 2017

For the second year, MM&M is honoring 16 of the most-senior women in the healthcare industry.

Commercial How pharma marketers are using behavioral science

How pharma marketers are using behavioral science

A tool kit of pharma case studies and advice for healthcare brands in making behavioral science a foundational part of a marketing strategy.

Top 40 Transformers Top 40 Healthcare Transformers of 2017

Top 40 Healthcare Transformers of 2017

MM&M honors 40 upstarts and veteran innovation gurus.